H
EMATOPOIETIC GROWTH factors (HGFs) are known to regulate both the in vitro and in vivo proliferation of various classes of human hematopoietic progenitor cells (HPC).',* HGFs not only promote mitosis and differentiation of HPC but also promote HPC ~urvival."~ Koury and Bondurant3 have shown that late-stage erythroid progenitor cells require erythropoietin for survival and that erythropoietin achieves this effect by retarding DNA breakdown, thereby preventing programmed cell death or apoptosi~.~ Recently, Bodine et aI5 have reported that interleukin-3 (IL-3) and c-kit ligand (KL) each promote the survival ofprimitive murine HPC that possess bone marrow (BM) repopulating ability and, thereby, resemble pluripotent hematopoietic stem cells (PHSC).' Furthermore, Katayama et aI6 have indicated that the survival of dormant murine lymphohematopoietic progenitor cells is dependent on the presence of either IL-3 or KL.
In this report, we present the results of experiments that were designed to determine the effects of KL and IL-3 on the survival of differentiated human HPC and of the more primitive HPC that resemble PHSC. We chose to examine the effects of these two HGFs on the survival of HPC and on the cells from which these HPC arise (pre-colony-forming cells [pre-CFC]) because they are known to profoundly influence the proliferative capacity of these two cell population~."'~ To directly assess the effects of KL and IL-3 on BM HPC and PHSC survival, we used different subpopulations of normal human BM enriched for each of these cell
Normal human BM cells that express CD34 and the major histocompatibility complex class I1 locus HLA-DR (CD34+ HLA-DR+) are enriched for a variety of differentiated HPC including the colony-forming unit-granulocyte-monocyte (CFU-GM); burst-forming unit-erythroid (BFU-E); CFU-granulocyte, erythroid, monocyte, megakarBlood, Vol83, No 6 (March 15), 1994: pp 1507-1 5 14 CD34+ HLA-DR+cells delayed the appearance of morphologic changes and DNA fragmentation patterns associated with cell death occurring by apoptosis. CD34+ HLA-DRc-kit+ cells were incubated under similar serum-free conditions in the presence or absence of IL-3 or KL, and the frequency of pre-CFC was determined by limiting dilution analysis. The frequency of pre-CFC in cells incubated for 48 hours in the absence of serum was similar to that of cells incubated in the presence of IL-3 and approximately doubled when CD34+ HLA-DR-c-kit+ cells were incubated in the presence of KL. Addition of KL to serum-free suspension cultures of CD34' HLA-DR-c-kit+ cells delayed the appearance of DNA fragmentation patterns associated with apoptosis to a greater extent than did the addition of IL-3. These studies suggest that IL-3, but not KL, promotes HPC survival, whereas KL plays a greater role than IL-3 in sustaining more primitive HPC, such as pre-CFC. The effects of both cytokines in mediating HPC and primitive hematopoietic cell survival appear to be related, in part, to their ability to suppress apoptosis. The CD34' HLA-DR-cell population has also been shown to have BM-populating ability using an in utero sheep transplantation model and, thereby, to possess numerous features associated with PHSC.I9 To assess the in vitro effects of HGFs on the survival of human PHSC, we have developed a quantitative means of enumerating human hematopoietic cells capable of generating HPC after 2 weeks in liquid suspension culture. For this purpose, we have performed a limiting dilution analysis (LDA) of pre-CFC present within CD34+ HLADR-c-kit+ cells that have been exposed for brief periods of time to either KL or IL-3.20,21
Cell death is now thought to be the consequence of two distinct processes, necrosis and apoptosis, that can be distinguished on the basis of a number of criteria. Apoptosis is an active event that depends on the synthesis of a novel set of mRNAs and proteins and is characterized by cell shrinkage rather than by the cellular swelling and lysis observed in necrosis.22-26 Perhaps the most notable characteristic of apoptosis is the synthesis or activation of an endonuclease that cleaves internucleosomal DNA, resulting in extensive degradation of DNA to oligonucleosomal fragments. [22] [23] [24] [25] [26] When such degraded DNA is extracted from apoptotic cells and analyzed by gel electrophoresis, a characteristic ladder of DNA fragmentation is observed. A number of HGFs have been shown to promote the survival of immortal hematopoietic precursor cell lines by suppressing apoptosis." Because such cell lines have an altered balance between apoptosis and proliferation that permits their continuous in vitro proliferation, normal human BM cells would be a more representative model system in which to evaluate the role of HGFs in modulating apoptosis and its impact on normal human hematopoie~is.~' Therefore, the study of normal BM cells is required to further define the role of apoptosis in HPC and PHSC development. Our data indicate that KL promotes the survival of primitive hematopoietic cells, whereas IL-3 plays a pivotal role in promoting the survival of more differentiated HPC.
MATERIALS AND METHODS
Cell separation techniques. BM samples were aspirated from the posterior iliac crest of normal volunteers after informed consent was obtained according to the guidelines established by the Human Investigation Committee ofthe Indiana University School of Medicine. Low-density mononuclear cells (LDBM) were isolated by density centrifugation of heparinized BM layered over Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) at 500g for 25 minutes. LDBM cells were suspended in phosphate-buffered saline (PBS), pH 7.4, containing 5% fetal bovine serum (FBS), 0.01% EDTA wt/vol, and 1.0 g/L D-glucose, and were injected into a Beckman counterflow centrifugal elutriation system at 10°C at a rotor speed of 1,950 rpm using a JA17 rotor and standard separation chamber (Beckman Instruments, Palo Alto, CA). A fraction of the LDBM obtained at a flow rate of I2 to 14 mL/min was collected as previously described. 28 For some experiments, elutriated BM cells were first stained for c-kit expression with a mouse antibody of the IgG,, subclass, SR-1, a gift of Dr Virginia Broudy (University of Washington School of Medicine, Seattle, WA)." After washing, SR-I was incubated with Texas-red (TR)-conjugated goat antimouse IgG2. (Southern Biotechnology, Birmingham, AL), and unbound active sites were blocked by mouse serum after washing. Cells were stained with phycoerythrin (PE)-conjugated mouse anti-CD34 and fluorescein isothiocyanate (F1TC)-conjugated mouse anti-HLA-DR (Becton Dickinson Immunocytometry Systems, San Jose, CA). Controls consisted of the corresponding isotype-matched, nonspecific myeloma proteins used in parallel with the staining monoclonal antibodies (MoAbs). Cells were stained at a concentration of 2 X lo7/ mL and washed after each step in 1% bovine serum albumin (BSA) in PBS.
FluorPscence-activuted cell sorting. Immediately after staining, cells were sorted on a Coulter Epics 753 dual-laser flow cytometer (Coulter Electronics, Hialeah, FL). TR was excited by 590-nm light emitted from a rhodamine 6-G dye laser. FITC and PE were excited using the 488-nm wavelength from a dedicated 6-W argon laser. O mL/well at 37°C in 100%-humidified 5% CO2 in air. Cultures received no additions, 100 ng/mL 1L-3 ( lo5 CFU/mg protein; Amgen Inc, Thousand Oaks, CA) or 1 pg/mL c-kit ligand ( 5 X IO5 CFU/ mg; Amgen), on initiation and after 48 hours of culture. At 24-or 48-hour intervals, cultures were harvested and viability was determined by trypan-blue exclusion. Then, the cultures were either assayed for hematopoietic progenitor cells, transferred to slides for morphologic examination after Wright-Giemsa staining, or the DNA was extracted for analysis of internucleosomal DNA fragmentation.
HPC assa.ys. Cells were suspended in plastic 35-mm tissue culture dishes (Costar, Cambridge, MA) containing l mL 30% FBS, 5 X mol/L 2-mercaptoethanol, I n&lmL GM-colony-stimulating factor (GM-CSF) (2 X 10' CFU/mg; Genzyme, Boston, MA), 1 U/mL human urinary erythropoietin (Toyobo CO Ltd, Osaka, Japan), 100 ng/mL c-kit ligand, 1 ng/mL IL-3, and 1,190 methylcellulose in IMDM. Cultures were incubated at 37°C in 100% humidified 5% CO2 in air. After 14 days, CFU-GM-, BFU-E-, and CFU-GEMM-derived colonies were enumerated in situ using an inverted microscope and standard criteria for their identification.
LDA ofpre-CFC. After 48 hours in serum-free suspension culture containing KL, IL-3, or no additions, CD34+ DR-or CD34+ DR-c-kit+ cells were washed and resuspended in IMDM containing 10% FBS. Cell counts were performed, and the cells were assayed in 96-wel1, flat-bottom tissue culture plates (Becton Dickinson Labware) in 0.2 mL IMDM/10% FBS at 200, 20, IO, 2, and I cell per well. All wells received IL-3 (1 ng/mL) and KL (100 ng/mL) at initiation and after 7 days in culture. After 14 days, the wells were scanned on an inverted microscope and wells containing proliferatingcells (those wells in which cell number had at least doubled) were scored. The cells in these wells were aspirated and were resuspended in 0.5 mL methylcellulose culture for assay of HPC containing KL, IL-3. and GM-CSF in the combinations described above. Those wells that contained cells which produced hematopoietic colonies in secondary cultures were considered to contain pre-CFC. Evaluation of the LDA was performed by the x minimilization method using the number of negative wells per given cell dilution."
Anulyses of internucleosornal DNA ,fragmentation. Internucleosomal DNA fragmentation was detected using the methods of Bhalla et al. 32 Cells were incubated with either IL-3 ( 100 ng/mL) or KL ( l pg/mL) in serum-free medium. Aliquots of 2.0 X IO4 cells were withdrawn after 18, 48, 72, and 96 hours. Cells were pelleted and washed with PBS at 4°C and disrupted by suspension for 20 minutes at 4°C in 5 mmol/L Tris-HCL buffer containing 0.5% (voll vol) Triton-X-100 and 20 mmol/L EDTA. The cellular lysates were centrifuged at 27,OOOg for 20 minutes to separate low-molecularweight DNA from intact chromatin. DNA was extracted from the supernatant by treatment with phenol and chloroform/isoamyl alcohol (25:24: l). To the upper aqueous layer placed in a fresh tube, 50 p L of 3 mol/L sodium acetate and 1 mL of 100% ethanol at 4°C were added to precipitate DNA. The mixture was vortexed and incubated for 30 to 60 minutes at -70°C. After a cold centrifugation for 30 minutes, the supernatant was discarded, and the pellet was resuspended in 0.5 mL of TE buffer (10.0 mmol/L Tris-HCL and 1.0 mmol/L EDTA) at pH 8.0. After adding 10 pL of DNase-free RNase A to the suspension, it was vortexed and incubated for 30 minutes at 37'C. To this, 50 pL of 5 mol/L NaCl was added, and the phenol/chloroform/isoamyl alcohol extraction was repeated. DNA was precipitated with ethanol as above, was centrifuged, and the pellet was dried. DNA samples were mixed with 1 1 p L TE (pH 8.0)-loading buffer and 2 pL of 5X tracking dye containing glycerol, bromophenol blue, and xylene cyanol. The reaction mix was loaded into the wells of a 1% agarose gel, and electrophoresed in a I X Trisacetate-EDTA (TAE)-running buffer containing ethidium bromide. DNA was separated over 90 minutes at 60 volts. The electrophoresed DNA was transferred overnight to nylon membranes by standard capillary methods. Blots were UVcrosslinked and prehybridized at 60'C overnight in 50% formamide/ 10% dextran sulfate/ I% sodium dodecyl sulfate (SDS)/5.6% sodium chloride containing denatured salmon sperm DNA.
A random-primed "P-labeled cDNA probe was prepared from DNA by random hexamer priming by Prime-a-Gene (Fisher, Norcross, GA) from 100 pmol/L Ara-Ctreated HL-60 cells. The cDNA probe was heatdenatured, cooled, and DNA on the membrane was hybridized for 18 to 24 hours at 60'C. The hybridized blots were washed twice for I5 minutes each in 2 X SSC buffer (0.15 mol/L NaCUO.0 15 rnol/L sodium citrate buffer) containing 0. I % SDS at room temperature, followed by two 15-minute washes in 0. I X SSC buffer containingo. 1% SDS at 6YC, and finally washed twice for 15 minutes each in 0.2 X SSC buffer with 0.1% SDS at 65'C. The blots were then exposed to Kodak XOmat AR films (Eastman-Kodak, Rochester, W ) with intensifying screens. The films were scanned by densitometry.
RESULTS
We initially determined the effect of serum on the survival of CD34+ HLA-DR+ cells. As can be seen in Fig 1, the viability of CD34' HLA-DR' cells maintained under serum-free conditions declined rapidly. After 96 hours of incubation, less than 10% of these cells remained viable. By contrast, 4 1 % of cells suspended in 2% serum and 55% of cells suspended in 10% serum remained viable after 96 hours of incubation. By 96 hours, some proliferation was detectable in the serum-containing cultures, as evidenced by increased viable cell count. We next determined the number of assayable progenitor cells that persisted when CD34' DR' cells were maintained under these same culture conditions ( Table 1) . After 96 hours of incubation under serumfree conditions, neither CFU-GM, BFU-E, or CFU-GEMM were assayable. By contrast, considerable numbers of progenitor cells persisted if the CD34+ DR' cells were suspended in 2% serum, and even greater numbers of CFU-GM and CFU-GEMM remained assayable at 96 hours if the o + o
f 6
Cultures initiated with 1.5 X 1 O4 CD34+ DR+ cells in mL serum-free or serum-containing medium and assayed at initiation (0 h). 24 hours, 48 hours, 96 hours, and 7 days (168 h) after initiation in methylcellulose containing KL ( 1 0 0 ng/mL), 11-3 (1 ng/mL), GM-CSF (1 ng/mL). and purified human ewhropoietin (1 U/mL); all cultures incubated at 37'C in 5% COz in air. Each point represents the mean f SD of duplicate points.
IMDM alone. t IMDM containing 2% heat-inactivated FBS.
* IMDM containing 10% heat-inactivated FBS. § CFU-GM-derived colonies scored at day 14 of incubation.
11 BFU-E-derived colonies scored at day 14 of incubation.
ll CFU-GEMM-derived colonies scored at day 14 of incubation.
For CD34+ HLA-DRf cells were suspended in medium containing 10% serum.
Because serum was shown to have such a favorable effect on the survival of CD34' HLA-DR+ cells, the effects of various HGFs on CD34' HLA-DR' cell survival and progenitor cell survival were examined under serum-free conditions. As is shown in Fig 2, few CD34 ' HLA-DR' cells remained viable after incubation for 96 hours in serum-free medium alone (viability, 6.8% k 3.2%) or serum-free medium containing KL (viability, 3.0% ? 2.8%). Conversely, when CD34' HLA-DR' cells were incubated in the presence of IL-3, 66.7% * 2.3% of the cells remained viable. In Table 2 , the effect of such cytokine additions on progenitor cell survival is shown. CD34' HLA-DR+ cells suspended in serum-free medium alone or in the presence of KL contained less than 10% of the initially assayable progenitor cells after 96 hours of incubation; cells suspended in the presence of IL-3, by contrast, contained significantly greater numbers of two classes of HPCs after a similar period of incubation (40% of original total HPC number). The ability of IL-3 to maintain survival of progenitor cells (P < .05) was confined to its effects on BFU-E and CFU-GEMM, whereas the effect on the CFU-GM was not statistically significant. The mechanism by which CD34' HLA-DR' cell death occurred and how cell survival was influenced by the addition of HGFs was examined next. In Fig 3A the morphologic appearance of Wright-Giemsa-stained CD34' HLA-DR' cells immediately after isolation from BM is shown. The intact cells were characterized by a high nuc1ear:cytoplasmic ratio and contained nuclei with multiple, prominent nucleoli. After 96 hours, CD34' HLA-DR+ cells maintained in serum-free medium alone or serum-free medium containing KL were morphologically quite different (Figs 3B and C). These cells were remarkable for loss of cellular and nuclear volume, cytoplasmic ruffling, nuclear fragmentation, and the formation of apoptotic bodies that contained nuclear components. These morphologic changes are characteristic of cells undergoing apoptosis. By contrast, cells suspended in serum-free medium containing IL-3 ( Fig 3D) displayed none of the cytoplasmic or nuclear features associated with apoptosis.
Biochemical evidence of apoptosis in this highly enriched HPC population was also obtained. Autoradiographs of the electrophoresed, Southem-blotted low-molecular-weight DNA extracted from the CD34' HLA-DR+ cells suspended in serum-free medium or serum-free medium containing KL or IL-3 are shown in Figs 4A , B, and C. CD34' HLA-DR' cells suspended in serum-free medium alone or serumfree medium containing KL displayed, within I8 to 48 hours, the typical ladder pattern of DNA degradation associated with apoptosis. By contrast, addition of IL-3 delayed the appearance of this characteristic pattern of DNA degradation until 72 hours of incubation in serum-free suspension culture.
Attempts to study the CD34+ HLA-DR-cell population by assessing HPC survival or cellular viability resulted in ambiguous results (data not shown). Because this fraction of BM cells is known to contain the precursors of HPC,8.y,18,19 HPC assays of this population after HGF exposure were thought not to reflect the effect of these HGFs on PHSC. To study the effects of HGFs on cells that more closely resemble PHSC, a more discretely defined fraction of cells enriched for PHSC was obtained, and a more appropriate assay system for the quantitation of assayable cells more primitive than HPC was developed. By using an MoAb to the c-kit receptor coupled with the use of an assay intended to quantitate the effects of HGFs on the cells that eventually give rise to HPC, both of these goals were achieved.
To directly assess the effects of IL-3 and KL on pre-CFC survival, we incubated CD34' HLA-DR-c-kit+ cells for 48 hours under these three conditions and, next, established multiple microsuspension cultures of these cells in limiting dilution. Cultures capable of giving rise to hematopoietic colonies after 2 weeks in suspension were enumerated to determine the frequency of pre-CFC (Fig 5 and Table 3 ). The frequency of pre-CFC in CD34' HLA-DR-c-kit cells at time 0 ranged from 2.65% to 17.31% (mean, 9.98%). The frequency of LTBMC-IC declined when CD34' HLA-DRc-kit+ cells were suspended for 48 hours in serum-free medium alone or in serum-free medium containing IL-3. Al- For though IL-3 appeared to consistently support higher numbers of LTBMC-IC than did serum-free culture alone, this effect was not statistically significant at the a = .05 level.
Although the frequency of LTBMC-IC in cells suspended in KL also declined to some extent, KL did promote the survival of significantly greater numbers of LTBMC-IC in all such studies performed. The mechanism by which KL promoted survival of LTBMC-IC was explored by examining the DNA fragmentation patterns of CD34+ HLA-DR-c-kit+ cells maintained for 18, 48, and 72 hours in serum-free medium alone, serum-free medium and IL-3, or serum-free medium and KL (Fig 6) . DNA ladders characteristic of apoptosis were observed by 72 hours in cells maintained in medium alone or in medium containing IL-3. By comparison, cells maintained in KL did not display a similar pattern of DNA degradation during this 72-hour incubation period (Fig 6) . These characteristic DNA ladders were also observed after 96 hours of incubation in serum-free medium in the presence of KL as well as of IL-3 (data not shown).
DISCUSSION
We have examined the effects of KL and IL-3 on the survival of human HPC (CFU-GM, BFW-E, and CFU-GEMM) and of more primitive cells that later give rise to HPC which resemble the PHSC. To directly address this question we have used subpopulations of BM cells specifically enriched for each of these cellular compartments that are at different stages of development along the hematopoietic cellular hierarchy.
The effect of serum on the survival of CD34' DR' cells, which are enriched for more differentiated HPC, was initially assessed. Serum alone was able to promote the survival of HPC. This effect was likely caused by the numerous nutrients and HGFs present within serum. Under serum-free conditions, IL-3 but not KL was able to preserve the viability of CD34+ DR' BM cells and, to a large extent, maintain the numbers of assayable progenitor cells present within these cell suspensions. It is important to note that the effect of IL-3 was limited to its action on BFU-E and CFU-GEMM and was not statistically demonstrable against CFU-GM. These data suggest that additional cytokines such as G-CSF or GM-CSF might be primarily responsible for maintaining CFU-GM survival.
To obtain quantitative data on the effect of these HGFs on the more primitive cells present within CD34' HLA-DR-c-kit' cells, we used LDA. After incubating CD34' HLA-DR c-kit+ cells for 48 hours in the presence or absence of either IL-3 or KL, the numbers of pre-CFC that persisted were quantitated. Although IL-3 promoted survival of these pre-CFC to a modest degree, its influence was not found to be statistically significant. By contrast, KL maintained the frequency of pre-CFC to a measurably greater extent. Our data differ somewhat from the reports of others who have attempted to assess the effects of cytokines on murine HPC and PHSC. Both Bodine et al' and Katayama et aI6 have reported that IL-3 or KL alone were equally effective in supporting primitive, dormant hematopoietic ' In the present report, KL was capable of promoting the survival of the most primitive HPC but not of the more differentiated HPC, whereas the effect of IL-3 was primarily on the more differentiated cell population. The reasons for the differences between our data and that previously reported by others are either methodologic in origin or caused by species differences. In our studies, we used subpopulations of human BM that were highly enriched for HPC or for the precursors of HPC, whereas both Bodine et al' and Katayama et aI6 used murine BM harvested after 5 fluorouracil administration to examine the effects of HGF on PHSC survival. Such murine BM specimens are enriched for PHSC but still contain a significant number of accessory cells that are capable of secondarily elaborating cytokines that might alter cell survival. Furthermore, in the studies described here, cells were suspended in serum-free medium to which IL-3 or KL were added. Bodine et al' and Katayama et aI6 each used serum-containing suspension culture systems for their
In this report, the presence of serum was shown to favor HPC survival. Therefore, the use of serum in such culture systems may prevent one from clearly defining the effects of specific HGFs on HPC and PHSC survival.
In this report, the means by which cell death occurs within these populations was examined. Analysis of CD34+ HLA-DR' cells incubated in serum-free medium showed characteristic morphologic changes associated with apoptosis. In addition, DNA extracted from both CD34+ HLA-DR+ and CD34+ HLA-DR-c-kit+ cell populations showed extensive degradation of DNA characteristic of apoptosis. Remarkably, IL-3, but not KL, was able to delay the appearance of these morphologic changes and of DNA degradation patterns in CD34+ HLA-DR' cells, whereas KL, but not IL-3, was able to delay the appearance of these same events in CD34' HLA-DR-c-kit+ cells. In the CD34' HLA-DR' population, the possibility exists that induction of cells by IL-3 to cycling and, thus, division might dampen or "dilute" detection of the presence of apoptotic cells or degraded DNA in the samples. However, this phenomenon would likely require more than 48 hours to play a significant, if any, role in these measurements, because proliferation of cells in this minimal serum-free system was not detected. However, after several days this might be a concern under conditions favoring proliferation. The more quiescent CD34' HLA-DR-c-kit' cells showed no evidence whatsoever of expansion during the period of observation. This series of studies suggests that IL-3 delays death of CD34' HLA-DR' cells, especially that of BFU-E and CFU-GEMM, whereas KL delays death of CD34' HLA-DR-ckit' cells by suppressing apoptosis.
These findings are consistent with a hierarchy of cytokines affecting hematopoietic cell survival, with KL delaying apoptosis of the most primitive HPC and IL3 delaying apoptosis of more differentiated HPC. Williams et a14 have shown that IL-3, GM-CSF, and G-CSF are each capable of suppressing apoptosis of murine HPC lines and suggest that these cytokines may be important in regulating the size of hematopoietic precursor populations in normal BM. The studies of Williams et a14 were performed using immortal cell lines that have a defect in the balance between cell death and proliferation. Yu et a17 have reported that erythropoietin delays apoptosis of murine fetal liver erythroblasts and that KL and IL-3 have a measurable, albeit limited, ability to protect these same fetal hematopoietic precursors from apopt~sis.~ However, the data presented in this report indicate that KL and IL-3 both affect apoptosis of hematopoietic cells even more primitive than precursor cell^"^.^ and that each of these cytokines plays a specific role in altering the programmed cell death of progenitor cells at different points along the hematopoietic cellular hierarchy. 
